Results 181 to 190 of about 2,247 (204)

Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?

Journal of Antimicrobial Chemotherapy, 2020
Elin M Svensson, Jakko van Ingen, Heiman Frank Louis Wertheim   +2 more
exaly  

New Oxazolidinone: Tedizolid

2023
openaire   +1 more source

Differences in Pharmacokinetic/Pharmacodynamic Parameters of Tedizolid Against VRE and MRSA

Pharmaceutical Research, 2022
Kazuaki Taguchi, Kazuaki Matsumoto, Yuki Enoki   +2 more
exaly  

Fosfato de tedizolid (antibacteriano) síntesis

2022
Torres, Hector, La Parra, Mario González-De   +1 more
openaire   +1 more source

Tedizolid Phosphate

Stephanie J. Phelps, Tracy M. Hagemann, Kelley R. Lee   +2 more
openaire   +2 more sources

Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic.

Clinical Infectious Diseases, 2015
Steven D Burdette
exaly  

Tedizolid

2018
openaire   +1 more source

In Vitro Activity of Tedizolid against Mycobacterium tuberculosis.

Antimicrobial Agents and Chemotherapy, 2019
Manuel Causse, Manuel Vaquero, Manuel Casal   +2 more
exaly  

In Vitro Susceptibility Testing of Tedizolid against Nontuberculous Mycobacteria.

Journal of Clinical Microbiology, 2017
Barbara A Brown-Elliott
exaly  

In vitro activity of tedizolid against staphylococci isolated from prosthetic joint infections

Diagnostic Microbiology and Infectious Disease, 2016
Melissa Karau, Suzannah M Schmidt-Malan
exaly